Vasopressin impairs brain, heart and kidney perfusion: An experimental study in pigs after transient myocardial ischemia

Critical Care

Volumn 12, Issue 1, 2008, Pages

  Müller, Stig ^a   How, Ole Jakob ^a   Hermansen, Stig Eggen ^a,b   Stenberg, Thor Allan ^a   Sager, Georg ^a   Myrmel, Truls ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

VASOPRESSIN; ARGIPRESSIN; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; CARDIOGENIC SHOCK; CORONARY ARTERY BLOOD FLOW; DRUG RESPONSE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEMODYNAMIC MONITORING; KIDNEY BLOOD FLOW; LOW DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORGAN BLOOD FLOW; OXYGEN SATURATION; PRIORITY JOURNAL; RISK ASSESSMENT; SWINE; VASCULAR RESISTANCE; VASOCONSTRICTION; ANIMAL; BRAIN; DRUG EFFECT; HEART MUSCLE REPERFUSION; KIDNEY; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ANIMALS; ARGININE VASOPRESSIN; BRAIN; CARDIAC OUTPUT; CORONARY CIRCULATION; KIDNEY; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; SWINE; VASOCONSTRICTOR AGENTS;

EID: 41049104011     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6794     Document Type: Article

References (39)

1. Argenziano M Chen JM Choudhri AF Cullinane S Garfein E Weinberg AD Smith CR Jr Rose EA Landry DW Oz MC Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent J Thorac Cardiovasc Surg 1998, 116:973-980. 10.1016/ S0022-5223(98)70049-2 9832689
2. Sharshar T Blanchard A Paillard M Raphael JC Gajdos P Annane D Circulating vasopressin levels in septic shock Crit Care Med 2003, 31:1752-1758. 10.1097/01.CCM.0000063046.82359.4A 12794416
3. Landry DW Levin HR Gallant EM Ashton RC Jr Seo S D'Alessandro D Oz MC Oliver JA Vasopressin deficiency contributes to the vasodilation of septic shock Circulation 1997, 95:1122-1125. 9054839
4. Patel BM Chittock DR Russell JA Walley KR Beneficial effects of short-term vasopressin infusion during severe septic shock Anesthesiology 2002, 96:576-582. 10.1097/00000542-200203000-00011 11873030
5. Jolly S Newton G Horlick E Seidelin PH Ross HJ Husain M Dzavik V Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction Am J Cardiol 2005, 96:1617-1620. 10.1016/j.amjcard.2005.07.076 16360345
6. Luckner G Dunser MW Jochberger S Mayr VD Wenzel V Ulmer H Schmid S Knotzer H Pajk W Hasibeder W Mayr AJ Friesenecker B Arginine vasopressin in 316 patients with advanced vasodilatory shock Crit Care Med 2005, 33:2659-2666. 10.1097/01.CCM.0000186749.34028.40 16276194
7. Miyachi K Ichinohe T Kaneko Y Effects of local injection of prilocaine-felypressin on the myocardial oxygen balance in dogs Eur J Oral Sci 2003, 111:339-345. 10.1034/j.1600-0722.2003.00050.x 12887400
8. Ertmer C Morelli A Bone HG Stubbe HD Schepers R Van AH Lange M Broking K Lucke M Traber DL Westphal M Dobutamine reverses the vasopressin-associated impairment in cardiac index and systemic oxygen supply in ovine endotoxemia Crit Care 2006, 10:R144. 1751059 17032443 10.1186/cc5065
9. Johnson KB Pearce FJ Jeffreys N McJames SW Cluff M Impact of vasopressin on hemodynamic and metabolic function in the decompensatory phase of hemorrhagic shock J Cardiothorac Vasc Anesth 2006, 20:167-172. 10.1053/ j.jvca.2005.11.015 16616655
10. Shelly MP Greatorex R Calne RY Park GR The physiological effects of vasopressin when used to control intra-abdominal bleeding Intensive Care Med 1988, 14:526-531. 10.1007/BF00263525 3065389
11. Medel J Boccara G Van de SE Bertrand M Godet G Coriat P Terlipressin for treating intraoperative hypotension: Can it unmask myocardial ischemia? Anesth Analg 2001, 93:53-55. 10.1097/00000539-200107000-00012 11429338
12. O'Brien A Clapp L Singer M Terlipressin for norepinephrine-resistant septic shock Lancet 2002, 359:1209-1210. 10.1016/S0140-6736(02)08225-9 11955542
13. Lauzier F Levy B Lamarre P Lesur O Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial Intensive Care Med 2006, 32:1782-1789. 10.1007/s00134-006-0378-0 17019548
14. Holmes CL Patel BM Russell JA Walley KR Physiology of vasopressin relevant to management of septic shock Chest 2001, 120:989-1002. 10.1378/ chest.120.3.989 11555538
15. Mayr VD Wenzel V Wagner-Berger HG Stadlbauer KH Cavus E Raab H Muller TH Jochberger S Dunser MW Krismer AC Schwarzacher S Lindner KH Arginine vasopressin during sinus rhythm: Effects on haemodynamic variables, left anterior descending coronary artery cross sectional area and cardiac index, before and after inhibition of NO-synthase, in pigs Resuscitation 2007, 74:366-371. 10.1016/j.resuscitation.2006.07.030 17621455
16. Korvald C Elvenes OP Ytrebo LM Sorlie DG Myrmel T Oxygen-wasting effect of inotropy in the "virtual work model " Am J Physiol 1999, 276:H1339-H1345. 10199860
17. Korvald C Elvenes OP Aghajani E Myhre ES Myrmel T Postischemic mechanoenergetic inefficiency is related to contractile dysfunction and not altered metabolism Am J Physiol Heart Circ Physiol 2001, 281:H2645-H2653. 11709434
18. Sager G Trovik T Slordal L Jaeger R Prytz PS Brox J Reikeras O Catecholamine binding and concentrations in acute phase plasma after surgery Scand J Clin Lab Invest 1988, 48:419-424. 10.3109/ 00365518809085751 3144732
19. Sager G Slordal L Huseby NE Florholmen J Beta-adrenoceptor regulation in insulin-dependent diabetes mellitus Scand J Clin Lab Invest 1991, 51:283-288. 10.3109/00365519109091616 1652786
20. Mirsky I Assessment of diastolic function: Suggested methods and future considerations Circulation 1984, 69:836-841. 6697466
21. Aghajani E Muller S Kjorstad KE Korvald C Nordhaug D Revhaug A Myrmel T The pressure-volume loop revisited: Is the search for a cardiac contractility index a futile cycle? Shock 2006, 25:370-376. 10.1097/ 01.shk.0000209521.20496.7a 16670639
22. Michel JB Tedgui A Bardou A Levy B Effect of vasopressin on phasic coronary blood flow Basic Res Cardiol 1985, 80:221-230. 10.1007/ BF01907898 4026782
23. Graf BM Fischer B Martin E Bosnjak ZJ Stowe DF Differential effects of arginine vasopressin on isolated guinea pig heart function during perfusion at constant flow and constant pressure J Cardiovasc Pharmacol 1997, 29:1-7. 10.1097/00005344-199701000-00001 9007663
24. Bax WA Van der Graaf PH Stam WB Bos E Nisato D Saxena PR [Arg8]vasopressin-induced responses of the human isolated coronary artery: Effects of non-peptide receptor antagonists Eur J Pharmacol 1995, 285:199-202. 10.1016/0014-2999(95)00503-D 8566139
25. Medel J Boccara G Van de SE Bertrand M Godet G Coriat P Terlipressin for treating intraoperative hypotension: Can it unmask myocardial ischemia? Anesth Analg 2001, 93:53-5. TOC 10.1097/00000539-200107000-00012 11429338
26. Malay MB Ashton JL Dahl K Savage EB Burchell SA Ashton RC Jr Sciacca RR Oliver JA Landry DW Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock Crit Care Med 2004, 32:1327-1331. 10.1097/ 01.CCM.0000128578.37822.F1 15187515
27. Lindner KH Prengel AW Pfenninger EG Lindner IM Strohmenger HU Georgieff M Lurie KG Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs Circulation 1995, 91:215-221. 7805205
28. Ericsson BF Hemodynamic effects of vasopressin. An experimental study in normovolemic and hypovolemic anesthetized dogs Acta Chir Scand Suppl 1971, 414:1-29. 4935762
29. Martikainen TJ Uusaro A Tenhunen JJ Ruokonen E Dobutamine compensates deleterious hemodynamic and metabolic effects of vasopressin in the splanchnic region in endotoxin shock Acta Anaesthesiol Scand 2004, 48:935-943. 10.1111/j.0001-5172.2004.00435.x 15315609
30. Walker BR Childs ME Adams EM Direct cardiac effects of vasopressin: Role of V1- and V2-vasopressinergic receptors Am J Physiol 1988, 255:H261-H265. 2970231
31. Fujisawa S Iijima T On the inotropic actions of arginine vasopressin in ventricular muscle of the guinea pig heart Jpn J Pharmacol 1999, 81:309-312. 10.1254/jjp.81.309 10622221
32. 2+] in the neonatal rat cardiomyocyte. Evidence for V1 subtype receptors Circ Res 1991, 69:239-245. 2054937
33. Chandrashekhar Y Prahash AJ Sen S Gupta S Roy S Anand IS The role of arginine vasopressin and its receptors in the normal and failing rat heart J Mol Cell Cardiol 2003, 35:495-504. 10.1016/S0022-2828(03)00053-1 12738231
34. Khayyal MA Eng C Franzen D Breall JA Kirk ES Effects of vasopressin on the coronary circulation: Reserve and regulation during ischemia Am J Physiol 1985, 248:H516-H522. 3985175
35. Tipayamontri U Young DB Nuwayhid BS Scott RE Analysis of the cardiovascular effects of arginine vasopressin in conscious dogs Hypertension 1987, 9:371-378. 3557603
36. Share L Role of vasopressin in cardiovascular regulation Physiol Rev 1988, 68:1248-1284. 3054948
37. Novella S Martinez AC Pagan RM Hernandez M Garcia-Sacristan A Gonzalez-Pinto A Gonzalez-Santos JM Benedito S Plasma levels and vascular effects of vasopressin in patients undergoing coronary artery bypass grafting Eur J Cardiothorac Surg 2007, 32:69-76. 10.1016/ j.ejcts.2007.03.047 17507236
38. Luckner G Mayr VD Jochberger S Wenzel V Ulmer H Hasibeder WR Dunser MW Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shock Crit Care Med 2007, 35:2280-2285. 17944015
39. Dunser MW Hasibeder WR Vasopressin in vasodilatory shock: Ensure organ blood flow, but take care of the heart! Crit Care 2006, 10:172. 1794457 17129364 10.1186/cc5089